BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28604746)

  • 21. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells.
    Sato M; Vaughan MB; Girard L; Peyton M; Lee W; Shames DS; Ramirez RD; Sunaga N; Gazdar AF; Shay JW; Minna JD
    Cancer Res; 2006 Feb; 66(4):2116-28. PubMed ID: 16489012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of integrin-dependent adhesion and signaling in EMT-like MDCK cells established through overexpression of calreticulin.
    Ihara Y; Inai Y; Ikezaki M
    J Cell Biochem; 2011 Sep; 112(9):2518-28. PubMed ID: 21557298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells.
    Gopal SK; Greening DW; Hanssen EG; Zhu HJ; Simpson RJ; Mathias RA
    Oncotarget; 2016 Apr; 7(15):19709-22. PubMed ID: 26919098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α6β1- and αV-integrins are required for long-term self-renewal of murine embryonic stem cells in the absence of LIF.
    Cattavarayane S; Palovuori R; Tanjore Ramanathan J; Manninen A
    BMC Cell Biol; 2015 Feb; 16():3. PubMed ID: 25886986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Radil as a Ras binding partner and putative activator.
    Choi BH; Kou Z; Colon TM; Chen CH; Chen Y; Dai W
    J Biol Chem; 2021; 296():100314. PubMed ID: 33482197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin αv promotes proliferation by activating ERK 1/2 in the human lung cancer cell line A549.
    Fu S; Fan L; Pan X; Sun Y; Zhao H
    Mol Med Rep; 2015 Feb; 11(2):1266-71. PubMed ID: 25370835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interplay among Drosophila transcription factors Ets21c, Fos and Ftz-F1 drives JNK-mediated tumor malignancy.
    Külshammer E; Mundorf J; Kilinc M; Frommolt P; Wagle P; Uhlirova M
    Dis Model Mech; 2015 Oct; 8(10):1279-93. PubMed ID: 26398940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
    Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
    Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs.
    Minjgee M; Toulany M; Kehlbach R; Giehl K; Rodemann HP
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1506-14. PubMed ID: 21985943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ectopic expression of Snail in MDBK cells does not induce epithelial-mesenchymal transition.
    Izawa G; Kobayashi W; Haraguchi M; Sudo A; Ozawa M
    Int J Mol Med; 2015 Jul; 36(1):166-72. PubMed ID: 25998899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation.
    Qiu XY; Hu DX; Chen WQ; Chen RQ; Qian SR; Li CY; Li YJ; Xiong XX; Liu D; Pan F; Yu SB; Chen XQ
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1754-1769. PubMed ID: 29510196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. aV integrins and TGF-β-induced EMT: a circle of regulation.
    Mamuya FA; Duncan MK
    J Cell Mol Med; 2012 Mar; 16(3):445-55. PubMed ID: 21883891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis.
    Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ
    Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P73 tumor suppressor and its targets, p21 and PUMA, are required for madin-darby canine kidney cell morphogenesis by maintaining an appropriate level of epithelial to mesenchymal transition.
    Zhang Y; Young A; Zhang J; Chen X
    Oncotarget; 2015 Jun; 6(16):13994-4004. PubMed ID: 26101856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspirin inhibits epithelial-to-mesenchymal transition and migration of oncogenic K-ras-expressing non-small cell lung carcinoma cells by down-regulating E-cadherin repressor Slug.
    Khan P; Manna A; Saha S; Mohanty S; Mukherjee S; Mazumdar M; Guha D; Das T
    BMC Cancer; 2016 Jan; 16():39. PubMed ID: 26810856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase.
    McFall A; Ulkü A; Lambert QT; Kusa A; Rogers-Graham K; Der CJ
    Mol Cell Biol; 2001 Aug; 21(16):5488-99. PubMed ID: 11463831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
    Kamarajan P; Kapila YL
    Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
    Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
    Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.